RON COHEN Insider Trading
Get free email notifications about insider trading for RON COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RON COHEN. RON COHEN is a in DYAX CORP ($DYAX) and a Director in DYAX CORP ($DYAX) and a President and CEO in ACORDA THERAPEUTICS INC ($ACOR).
Address: C/O ACORDA THERAPEUTICS, INC. 15 SKYLINE DRIVE HAWTHORNE 10532 NY
Companies in which RON COHEN is an Insider
ACORDA THERAPEUTICS INC
Trading Symbol: ACORIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RON COHEN: President and CEO
Holdings: 135,830 shares
Current Value: $2,879,596
Latest Transaction: Mar 05 2021
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYAX CORP
Trading Symbol: DYAXIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of RON COHEN:
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RON COHEN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 135,830 | 106.8 K to 135.8 K (+27.15 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 8,543 | 0 | 640,980 | 632.4 K to 641 K (+1.35 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 2.41 | 218,500 | 526,585 | 218,500 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 13.51 | 42,715 | 577,080 | 42,715 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 25,629 | 0 | 517,136 | 491.5 K to 517.1 K (+5.21 %) |